Basic Information
Our mission is to leverage biotechnology to simplify and democratize the treatment of pulmonary arterial hypertension (PAH) and other fatal organ diseases.
Lung Biotechnology PBC
Maryland,United States of America
15~50 people
January 01, 1997
ir@unither.com